Edgewell Personal Care vs Interparfums
EPC and IPAR side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EPC and IPAR compare
Interparfums is the larger company, worth 3.4 times as much as Edgewell Personal Care ($4.3B against $1.3B).
Interparfums grew revenue faster over the last twelve months (2.6% versus 1.8% for Edgewell Personal Care).
Interparfums keeps more of each dollar of sales as profit, with a net margin of 11.3% compared with −2.6% at Edgewell Personal Care.
Both pay dividends: Edgewell Personal Care yields 2.2% and Interparfums 2.4%.
Interparfums scores higher on the StockData Score (20 against 4 for Edgewell Personal Care), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EPC | IPAR |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $4.3B |
| Share price | $27.28 | $133.37 |
| Change, 1 year | 44.3% | 50.6% |
| Change, 5 years | −38.2% | 44.1% |
| Beta (5Y) | 0.67 | 0.85 |
| Employees | 6,700 | 662 |
| StockData Score | ||
| Total score | 4 | 20 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | – | 25.1× |
| P/S | 0.6× (better) | 2.8× |
| P/B | 0.9× (better) | 4.9× |
| EV/EBITDA | 17.8× | 15.7× (better) |
| P/FCF | – | 17.5× |
| PEG | – | 2.18 |
| FCF yield | −0.80% | 5.7% (better) |
| Fair value | $18.83 | $148.09 |
| Margin of safety | −44.9% | 9.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.8% | 2.6% (better) |
| Revenue growth, 5Y average | −0.89% | 22.5% (better) |
| Net income growth (TTM) | −304% | 3.4% (better) |
| EPS growth (TTM) | −311% | 3.7% (better) |
| EPS growth, 5Y average | – | 34.1% |
| Profitability | ||
| Gross margin | 41.6% | 64.8% (better) |
| Operating margin | 2.1% | 17.9% (better) |
| Net margin | −2.6% | 11.3% (better) |
| FCF margin | −0.50% | 16.2% (better) |
| Return on equity | −3.4% | 19.5% (better) |
| Return on invested capital | 1.3% | 20.8% (better) |
| Financial health | ||
| Debt / equity | 0.85 | 0.22 (better) |
| Net debt / EBITDA | 7.30 | 0.29 (better) |
| Interest coverage | 0.6× | 44.3× (better) |
| Current ratio | 1.82 | 3.33 (better) |
| Altman Z-score | 1.53 | 8.26 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | 2.4% (better) |
| Payout ratio | – | 60.2% |
| Years of dividend growth | – | 5 |
| Dividend growth, 5Y average | – | 57.5% |
| Buyback yield | 1.3% (better) | 0.24% |
| Shareholder yield | 3.5% (better) | 2.6% |
| Ownership | ||
| Held by institutions | 117% | 67.1% |
| Held by insiders | 1.5% | 22.3% |
| Insider net buying, 12 months | $0 (better) | −$4.0M |
| Short interest, % of float | 10.9% | 7.8% |
Go deeper
- EPC stock overview
- EPC income statement
- EPC valuation and score
- IPAR stock overview
- IPAR income statement
- IPAR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.